CDI

Clinical trials for CDI explained in plain language.

Never miss a new study

Get alerted when new CDI trials appear

Sign up with your email to follow new studies for CDI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a 14-Day pill break the cycle of recurrent c. diff?

Prevention Recruiting now

This study tests a new treatment called VE303 to see if it can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had C. diff before will take either VE303 or a placebo for 14 days. The main goal is to see if fewer people get another C. diff i…

Matched conditions: CDI

Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention

Last updated May 26, 2026 10:59 UTC

CDI

Get alerted when new CDI trials appear

Could a 14-Day pill break the cycle of recurrent c. diff?